Pain & Emergencies

Local Anesthesia Options for Patients with Heart Arrhythmias

This clinical guide explores safe dental anaesthesia for patients with cardiac arrhythmias. Learn how adrenaline and plain local anaesthetics affect heart rhythms, how clinicians prevent dental anaesthesia heart palpitations, and when to seek urgent medical care.

11 min read Written and clinically reviewed by Dr. Amit Sharma, Oral & Maxillofacial SurgeonLast reviewed 3 September 2026

At a glance

  • A cardiac arrhythmia is any disturbance in the normal rate, regularity, or sequence of cardiac electrical impulses.
  • Experiencing dental anesthesia heart palpitations is one of the most frequent cardiovascular complaints reported in the dental chair.
  • The subjective sensation of dental anesthesia heart palpitations varies among individuals.
  • Safe administration of local anaesthesia begins with an exhaustive medical history.
  • Dental practitioners stratify cardiovascular risk to determine which anaesthetic regimen and clinical environment are safest for each patient.

Understanding Heart Arrhythmias and Dental Anaesthesia

A cardiac arrhythmia is any disturbance in the normal rate, regularity, or sequence of cardiac electrical impulses. Under physiological conditions, the heart's natural pacemaker—the sinoatrial node located in the right atrium—generates coordinated electrical currents that propagate through the atrioventricular node, the bundle of His, and the Purkinje network. This organized pathway ensures efficient, rhythmic contractions of the atria and ventricles. Common dysrhythmias include atrial fibrillation, supraventricular tachycardia, premature ventricular contractions, and varying degrees of heart block. When a patient with an existing rhythm disturbance attends the dental clinic, the choice of local anaesthetic requires careful evaluation to ensure treatment does not exacerbate their baseline condition.

Local anaesthetics function by reversibly binding to voltage-gated sodium channels on nerve cell membranes, inhibiting the influx of sodium ions and blocking the generation and conduction of nociceptive (pain) signals. In restorative and surgical dentistry, local anaesthetic agents such as lignocaine (lidocaine), articaine, and mepivacaine are frequently combined with vasoconstrictors—most notably adrenaline (epinephrine). Vasoconstrictors narrow the local microvasculature, which confines the anaesthetic agent to the injection site, prolongs analgesia, and reduces systemic toxicity. However, because adrenaline is also an adrenergic receptor agonist that can stimulate cardiac tissue, dental clinicians must balance profound pain control against potential cardiovascular stimulation.

Mechanisms Behind Dental Anaesthesia Heart Palpitations

Experiencing dental anesthesia heart palpitations is one of the most frequent cardiovascular complaints reported in the dental chair. There are two primary pathophysiological drivers for this sensation: exogenous adrenergic stimulation from the anaesthetic solution itself, and endogenous catecholamine release triggered by acute pain or emotional stress. When a local anaesthetic containing adrenaline is administered, even a minor systemic absorption can stimulate beta-1 adrenergic receptors in the myocardium, leading to an increased heart rate (positive chronotropy) and enhanced contraction strength (positive inotropy). If the needle tip inadvertently enters a micro-vessel, rapid intravascular uptake can trigger an immediate, noticeable surge in pulse rate.

Equally important, yet frequently underestimated, is the body's own production of adrenaline and noradrenaline. Dental anxiety, fear of needles, or inadequate local anaesthetic depth will provoke a potent autonomic fight-or-flight response. The quantity of endogenous catecholamines released by the adrenal medulla during acute distress or severe procedural pain often vastly exceeds the small, controlled dose of adrenaline present in a standard dental cartridge. In susceptible patients with subclinical myocardial irritability or documented arrhythmias, either mechanism—exogenous vasoconstrictor absorption or endogenous stress hormones—can provoke ectopic beats, sinus tachycardia, or transient palpitations.

Symptoms and Clinical Presentation

The subjective sensation of dental anesthesia heart palpitations varies among individuals. Patients commonly describe a sudden flutter, a racing pulse, a forceful thumping behind the sternum, or a sensation of the heart 'skipping a beat' shortly after the injection is administered. In most healthy individuals or those with benign sinus tachycardia, these sensations are transient, peaking within two to three minutes and subsiding as the circulating adrenaline is rapidly metabolised by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO) enzymes in the liver and bloodstream.

However, in individuals with underlying cardiac conditions—such as atrial fibrillation, ventricular pre-excitation syndromes, or ischaemic heart disease—a transient adrenergic challenge may precipitate a sustained dysrhythmia. Concerning presentations include sudden lightheadedness, presyncope (feeling faint), shortness of breath (dyspnoea), diaphoresis (profuse sweating), or a prolonged resting heart rate exceeding 120 beats per minute. Recognizing the distinction between a benign, self-limiting stress response and an unstable cardiac event is critical for patient safety.

Pre-Operative Assessment and Medical Evaluation

Safe administration of local anaesthesia begins with an exhaustive medical history. The dental clinician must identify the precise type of arrhythmia, its underlying cause, the frequency of symptomatic episodes, and any implantable cardiac devices, such as permanent pacemakers or implantable cardioverter-defibrillators (ICDs). The patient's functional reserve is typically evaluated using Metabolic Equivalents of Task (METs); an ability to climb two flights of stairs or walk briskly on level ground without chest tightness or severe breathlessness indicates adequate functional capacity (greater than 4 METs) for routine dental procedures.

The clinician will also review all prescribed medications. Many patients with arrhythmias take class I to IV antiarrhythmic agents (such as flecainide, amiodarone, beta-blockers, or calcium-channel blockers), as well as direct-acting oral anticoagulants (DOACs like apixaban or dabigatran) or warfarin to prevent thromboembolism. Vital signs, including baseline blood pressure and resting radial pulse regularity, must be documented before administering any local anaesthetic. Where significant instability is suspected—such as uncontrolled paroxysmal arrhythmias or decompensated heart failure—the clinician will liaise directly with the patient's cardiologist before proceeding with elective care.

Cardiovascular Risk Stratification in Dentistry

Dental practitioners stratify cardiovascular risk to determine which anaesthetic regimen and clinical environment are safest for each patient. Low-risk patients include those with well-controlled atrial fibrillation, treated premature contractions without structural heart disease, or functioning cardiac pacemakers who are completely asymptomatic. These individuals can safely receive standard dental care in a primary care setting, provided appropriate anaesthetic selection and aspiration techniques are rigorously observed.

Moderate-to-high risk categories encompass patients with recent myocardial infarction (within the past three to six months), unstable angina, severe aortic stenosis, uncontrolled tachyarrhythmias, or high-grade atrioventricular block. In these complex cohorts, elective dental treatments are deferred until medical stabilization is achieved. For urgent dental interventions, care is frequently coordinated within a hospital-based oral and maxillofacial surgery unit with continuous electrocardiographic (ECG) and pulse oximetry monitoring, ensuring rapid access to resuscitation facilities.

Local Anaesthetic Selection and Adrenaline Safety

When managing patients prone to palpitations or arrhythmias, the primary decision involves choosing between vasoconstrictor-containing solutions and plain formulations. Standard dental cartridges commonly contain 2% lignocaine with 1:80,000 or 1:100,000 adrenaline. For patients with stable cardiovascular disease, international dental guidelines recommend limiting exogenous adrenaline to a 'cardiac dose' of 0.04 milligrams per appointment—equivalent to approximately two cartridges of 1:100,000 adrenaline or four cartridges of 1:200,000 adrenaline. Articaine 4% with 1:200,000 adrenaline offers high anaesthetic efficacy with a reduced vasoconstrictor concentration, making it a valuable option for infiltration techniques.

Where adrenaline is strictly contraindicated or in cases of severe adrenergic sensitivity, plain local anaesthetics provide safe alternatives. Mepivacaine 3% plain and prilocaine 3% plain contain no vasoconstrictor, exerting minimal direct cardiac stimulation. Alternatively, prilocaine 3% combined with felypressin (0.03 IU/mL) utilizes a synthetic non-catecholamine vasopressin analogue that promotes local haemostasis and prolongs anaesthesia via venous smooth muscle constriction rather than direct myocardial adrenergic stimulation. However, plain solutions possess a shorter duration of action, necessitating efficient procedural execution to avoid pain-induced endogenous stress.

Step-by-Step Clinical Protocol and Procedure

A cardiac-safe dental appointment begins long before the needle touches tissue. The patient is scheduled during morning hours when physical fatigue is low, and pre-operative baseline vital signs are recorded. The clinician creates a calm environment, clearly explaining each step to alleviate psychological stress. A high-potency topical anaesthetic gel (such as 20% benzocaine or 5% lignocaine) is applied to the dried mucosa for at least two minutes, minimizing the initial discomfort of needle penetration.

The injection technique itself is executed with meticulous precision. The clinician uses an aspirating syringe, drawing back gently in two distinct anatomical planes to confirm the needle has not entered a blood vessel. The anaesthetic solution is deposited very slowly—ideally over a duration of 60 to 90 seconds per cartridge. Slow delivery significantly reduces peak plasma concentrations of both the local anaesthetic drug and the vasoconstrictor, mitigating the abrupt physiological spikes that provoke dental anesthesia heart palpitations. The patient is monitored continuously for several minutes post-injection to verify profound numbness before dental work commences.

Managing Complications and Intra-Operative Emergencies

If a patient experiences an acute arrhythmia or sudden tachycardia during treatment, the dental team immediately suspends the procedure. The dental chair is adjusted to a position of comfort—typically semi-reclined, as lying completely flat can exacerbate respiratory distress in patients with cardiac compromise. The clinician reassesses airway, breathing, and circulation, checks the pulse for rate and regularity, and measures blood pressure and oxygen saturation. Reassurance is provided to lower autonomic arousal.

In the event of severe palpitations accompanied by chest pain, dizziness, or loss of consciousness, emergency medical protocols are initiated without delay. High-flow oxygen is administered if indicated, and emergency medical services are summoned. For patients with known ischaemic disease presenting with angina-like symptoms, sublingual glyceryl trinitrate (GTN) may be administered if systolic blood pressure exceeds 90 mmHg. Dental practices maintain automated external defibrillators (AEDs) and emergency cardiac drugs, ensuring immediate life support can be provided if a benign rhythm degenerates into a malignant dysrhythmia.

Prevention, Lifestyle, and Long-Term Considerations

Preventing adverse anaesthetic reactions requires continuous collaboration between the patient, general dental practitioner, and physician. Patients must be transparent regarding all lifestyle substances that influence cardiac conduction. In many global populations, including within South Asian communities, the habitual consumption of betel quid, paan, or gutka introduces arecoline and nicotine into the system. These substances act as potent autonomic stimulants, elevating baseline resting heart rates, exacerbating hypertension, and increasing myocardial irritability, which substantially magnifies the risk of palpitations when combined with dental vasoconstrictors.

Patients should also moderate high caffeine intake and avoid tobacco or electronic cigarettes prior to dental appointments. Practising relaxation techniques, maintaining strict compliance with prescribed daily cardiovascular medications, and requesting morning appointments can markedly diminish anxiety-driven sympathetic surges. Establishing an ongoing preventive dental maintenance schedule reduces the necessity for extensive emergency dental surgeries, allowing required treatments to be conducted under predictable, low-stress, and pharmacologically optimized conditions.

Evidence and further reading

Mainstream dental and cardiovascular guidelines consistently emphasize that profound local anaesthesia is crucial for preventing dangerous endogenous catecholamine release in cardiac patients. Systematic reviews published in the Journal of the American Dental Association (JADA) and consensus statements from the American Heart Association and the British Dental Association support the safe use of minimal adrenaline (up to 0.04 mg per session) for patients with stable cardiovascular disease and controlled arrhythmias. The evidence underscores that sub-therapeutic pain control poses a greater haemodynamic risk than a judiciously administered vasoconstrictor.

Guidance from the National Institute for Health and Care Excellence (NICE), the Resuscitation Council UK, and the Cochrane Database of Systematic Reviews highlights the paramount importance of pre-treatment cardiovascular risk assessment, active aspiration, and slow injection rates. For complex dysrhythmias, clinicians are directed to follow standardized multidisciplinary protocols developed in conjunction with cardiology societies to determine whether plain anaesthetics (such as mepivacaine) or felypressin-containing alternatives are preferred over standard adrenergic preparations.

Questions patients ask us

Why does my heart race immediately after a dental injection?
A racing heart is usually caused by either the small amount of adrenaline (vasoconstrictor) in the local anaesthetic or your body's natural adrenaline surge triggered by anxiety and fear. When injected, adrenaline can briefly stimulate the heart's beta-receptors, causing a harmless, temporary increase in rate that typically resolves within a few minutes.
Can I receive dental anaesthesia if I have atrial fibrillation?
Yes, patients with stable atrial fibrillation can safely receive local anaesthesia. Your dentist will typically use a lower concentration of adrenaline, limit the total volume to a 'cardiac dose' (maximum 0.04 mg adrenaline), or select a plain anaesthetic such as mepivacaine, while ensuring meticulous aspiration to prevent intravascular injection.
What is the difference between lidocaine and mepivacaine for heart patients?
Lignocaine (lidocaine) is usually combined with adrenaline to prolong numbness and reduce bleeding. Mepivacaine can be used in a 3% plain formulation without any vasoconstrictor. For patients with severe or unstable arrhythmias, plain mepivacaine avoids direct cardiac stimulation, though its duration of pain relief is shorter.
Are dental injections safe if I have a pacemaker or ICD?
Modern cardiac pacemakers and implantable cardioverter-defibrillators (ICDs) are fully shielded against dental anaesthetic solutions. Local anaesthetics themselves do not interfere with pacemaker electronics. However, your dentist will keep adrenaline doses low to prevent rapid heart rates from inadvertently triggering programmed ICD therapies.
Should I stop taking my heart rhythm or blood thinner medication before dental work?
No, you should never alter or stop your prescribed cardiac or anticoagulant medications without explicit instructions from your cardiologist or dentist. Stopping antiarrhythmics or blood thinners significantly increases your risk of stroke, blood clots, or severe rhythm disturbances during and after your dental procedure.
How does anxiety make heart palpitations worse during dental treatment?
When you feel anxious or frightened, your adrenal glands release endogenous adrenaline and noradrenaline into your bloodstream. This natural stress response often introduces significantly more adrenaline into your circulation than the tiny amount present in a dental injection, directly increasing heart rate and triggering extra heartbeats.
Does using paan, gutka, or tobacco affect how my heart handles dental anaesthesia?
Yes. Paan, gutka, and betel nut contain arecoline, and tobacco contains nicotine. Both are potent stimulants that raise resting blood pressure and baseline heart rate. Combining these substances with dental adrenaline increases the likelihood of heart palpitations, unexpected blood pressure spikes, and cardiac rhythm irregularities.
When should I seek urgent medical care after a dental injection?
While mild fluttering that fades quickly is common, you must seek urgent medical assessment if you experience crushing chest pain, radiating discomfort to the jaw or left arm, severe breathlessness, fainting, or a rapid, irregular heart rate that does not settle within 15 to 20 minutes.

When to see us

Get examined without waiting if any of the following applies to you:

  • Facial or neck swelling, difficulty swallowing, opening the mouth or breathing — this is an emergency
  • Pain with fever, or swelling that is spreading rather than settling
  • A tooth knocked out or pushed out of position after an injury — time matters
  • Pain that wakes you at night or does not respond to ordinary painkillers
Treated at this hospital

Get a written plan and cost before you commit

If this is what you are dealing with, the next step is a consultation with radiographs — pain & emergencies cases are seen by the specialist who handles that field. You get a written plan and staged cost before anything begins.

reception@dramitsharmahospital.com
Please note

This article is general education and does not replace an in-person examination, radiographs or a diagnosis by a qualified dentist.

Related in Pain & Emergencies

10 min read

Tooth Pain and Sensitivity: Causes, Relief and When to See a Dentist

Why teeth hurt or react to hot and cold, the difference between everyday sensitivity and a warning sign, and what treatment usually follows.

10 min read

Root Canal Treatment Explained

Why a tooth needs root canal therapy, what happens during single-sitting endodontics, and why crowns follow.

9 min read

Tooth Pain and Dental Emergencies

How to identify a genuine dental emergency, what to do in the first hour, and when to call the hospital immediately.

11 min read

Reversible vs Irreversible Pulpitis Symptoms and Treatment Options

Understanding reversible vs irreversible pulpitis is essential when managing dental pain. This guide explains their anatomical causes, diagnostic criteria, clinical symptoms, and evidence-based treatments ranging from conservative restorations to root canal therapy and emergency care.

11 min read

Differences Between a Tooth Abscess and Gum Abscess

A dental abscess is a localised collection of pus caused by bacterial infection. Distinguishing between a tooth abscess (periapical) and a gum abscess (periodontal) is vital, as their anatomical origins, clinical presentations, diagnostic pathways, and definitive treatments differ fundamentally.

10 min read

Why Tooth Pain Gets Worse When Lying Down

Experiencing toothache worse lying down typically indicates elevated pulpal or periapical pressure driven by increased cranial blood flow when supine. This guide explains pulpal anatomy, underlying causes, diagnostic pathways, evidence-based treatments, and critical red flags requiring emergency care.